Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus

NCT06446310 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

194

Enrollment

INDUSTRY

Sponsor class

Conditions

Uremic Pruritus

Interventions

DRUG: QLG2198
DRUG: Placebo

Sponsor

Qilu Pharmaceutical (Hainan) Co., Ltd.